These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 20207347

  • 41. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
    Park PW, Casiano EM, Escoto L, Claveria AM.
    Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412
    [Abstract] [Full Text] [Related]

  • 42. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D, Murphy M, Tseng LJ, Riordan HJ, Chatterjee A.
    Biol Psychiatry; 2011 Jun 01; 69(11):1075-82. PubMed ID: 21295286
    [Abstract] [Full Text] [Related]

  • 43. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG, Gitchell JG, Shiffman S, Sembower MA.
    Clin Ther; 2009 Sep 01; 31(9):1957-65. PubMed ID: 19843485
    [Abstract] [Full Text] [Related]

  • 44. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.
    Ashare RL, Wileyto EP, Ruparel K, Goelz PM, Hopson RD, Valdez JN, Gur RC, Loughead J, Lerman C.
    Drug Alcohol Depend; 2013 Dec 15; 133(3):852-6. PubMed ID: 24095246
    [Abstract] [Full Text] [Related]

  • 45. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
    Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K.
    Drug Alcohol Depend; 2013 Jul 01; 131(1-2):136-42. PubMed ID: 23298651
    [Abstract] [Full Text] [Related]

  • 46. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    Crunelle CL, Miller ML, Booij J, van den Brink W.
    Eur Neuropsychopharmacol; 2010 Feb 01; 20(2):69-79. PubMed ID: 19959340
    [Abstract] [Full Text] [Related]

  • 47. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism.
    Zhu DF, Wang ZX, Zhang DR, Pan ZL, He S, Hu XP, Chen XC, Zhou JN.
    Brain; 2006 Nov 01; 129(Pt 11):2923-30. PubMed ID: 16921178
    [Abstract] [Full Text] [Related]

  • 48. Neurobiological substrate of smoking-related attentional bias.
    Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IH.
    Neuroimage; 2011 Feb 01; 54(3):2374-81. PubMed ID: 20932921
    [Abstract] [Full Text] [Related]

  • 49. Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
    Umene-Nakano W, Yoshimura R, Yoshii C, Hoshuyama T, Hayashi K, Hori H, Katsuki A, Ikenouchi-Sugita A, Nakamura J.
    Hum Psychopharmacol; 2010 Apr 01; 25(3):276-9. PubMed ID: 20373480
    [Abstract] [Full Text] [Related]

  • 50. The modulatory effects of nicotine on parietal cortex activity in a cued target detection task depend on cue reliability.
    Giessing C, Thiel CM, Rösler F, Fink GR.
    Neuroscience; 2006 Feb 01; 137(3):853-64. PubMed ID: 16309846
    [Abstract] [Full Text] [Related]

  • 51. Efficacy and safety of varenicline for smoking cessation.
    Hays JT, Ebbert JO, Sood A.
    Am J Med; 2008 Apr 01; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [Abstract] [Full Text] [Related]

  • 52. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E.
    Biol Psychiatry; 2004 Sep 01; 56(5):349-55. PubMed ID: 15336517
    [Abstract] [Full Text] [Related]

  • 53. Functional magnetic resonance imaging of working memory among multiple sclerosis patients.
    Sweet LH, Rao SM, Primeau M, Mayer AR, Cohen RA.
    J Neuroimaging; 2004 Apr 01; 14(2):150-7. PubMed ID: 15095561
    [Abstract] [Full Text] [Related]

  • 54. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV, Petros T.
    Physiol Behav; 2006 Mar 30; 87(3):614-24. PubMed ID: 16466655
    [Abstract] [Full Text] [Related]

  • 55. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
    Roh S, Hoeppner SS, Schoenfeld D, Fullerton CA, Stoeckel LE, Evins AE.
    Psychopharmacology (Berl); 2014 Feb 30; 231(4):765-75. PubMed ID: 24114425
    [Abstract] [Full Text] [Related]

  • 56. Limbic over-activity in depression during preserved performance on the n-back task.
    Rose EJ, Simonotto E, Ebmeier KP.
    Neuroimage; 2006 Jan 01; 29(1):203-15. PubMed ID: 16157491
    [Abstract] [Full Text] [Related]

  • 57. Nicotine increases neural response to unpleasant stimuli and anxiety in non-smokers.
    Kobiella A, Ulshöfer DE, Vollmert C, Vollstädt-Klein S, Bühler M, Esslinger C, Smolka MN.
    Addict Biol; 2011 Apr 01; 16(2):285-95. PubMed ID: 20731637
    [Abstract] [Full Text] [Related]

  • 58. Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers.
    Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein EA.
    Neuroimage; 2013 Feb 01; 66():585-93. PubMed ID: 23110878
    [Abstract] [Full Text] [Related]

  • 59. [Varenicline--a new chance for smokers?].
    Goniewicz ML, Koszowski B, Czogała J, Sobczak A.
    Przegl Lek; 2007 Feb 01; 64(10):899-902. PubMed ID: 18409337
    [Abstract] [Full Text] [Related]

  • 60. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A.
    Arch Gen Psychiatry; 2011 Dec 01; 68(12):1195-206. PubMed ID: 21810630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.